Healthcare Unfiltered

Chadi is joined by entrepreneur Dan Bickford, co-founder of Confirma and creator of the CADstream computer-aided detection software, to explore how artificial intelligence is transforming breast cancer screening with MRI. They discuss which women are most likely to benefit from breast MRI—particularly those with dense breast tissue—the evidence supporting AI-assisted interpretation as an FDA-cleared workflow tool, and how the technology complements radiologists to improve accuracy and efficie...

In this new episode of Healthcare Unfiltered - Arabic Edition, Nagla and Chadi host Drs. and Professors Nevine Elabd and Mai Sherif to discuss what happens inside the medical laboratories, and how new technological advances in the laboratory, including artificial intelligence, are aiding and helping patients and the doctors that care for them. Check it out, share, subscribe, and join the conversation. في حلقة جديدة من Healthcare Unfiltered – النسخة العربية، أستضيف أنا ونجلاء الدكتورتين والأست...

In this deeply personal episode, Allison A. Fitzgerald, MD, PhD, a pancreatic oncologist at Dana-Farber Cancer Institute, reflects on the experience of losing her mother to cancer and the story she courageously shared in ASCO Connection. She discusses what prompted her to publish such an intimate account, the unique perspective of serving as both an oncologist and a caregiver, the emotional support that sustained her, and how her family and others in her life responded to her essay. Dr. Fitzg...

In this thought-provoking episode, Chadi Nabhan sits down with Thomas Seyfried, PhD, professor of biology at Boston College, to explore his controversial and unconventional views on cancer metabolism, the ketogenic diet, and the role of sugar in cancer development. Dr. Seyfried explains the science behind metabolic therapy, the origins of the glucose ketone index (GKI), why ketogenic diets have long been used to treat epilepsy, and his belief that restricting glucose and glutamine can prevent...

Neeta Somaiah, MD, of The University of Texas MD Anderson Cancer Center, provides a comprehensive overview of bone and soft tissue sarcomas, exploring how molecular classification and histology guide treatment decisions, the major therapeutic breakthroughs and drug approvals that have reshaped the field over the past decade, and current approaches to curative-intent therapy, including surgery, radiation, and adjuvant treatment strategies. The conversation also examines the management of advan...